NBE 105
Alternative Names: NBE-105Latest Information Update: 28 Mar 2025
At a glance
- Originator NBE-Therapeutics
- Class Anthracyclines; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action DNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Mar 2025 No recent reports of development identified for research development in Solid-tumours in Switzerland